Asahi Intecc (7747.T) Financial Analysis & Valuation | Quarter Chart
Asahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical devices in Japan, the United States, Europe, the Middle East, China, and internationally. The company provides percutaneous transluminal coronary angioplasty (PTCA) guide wires, PTCA guiding catheters, PTCA balloon c... more
Asahi Intecc Co., Ltd. engages in the development, manufacture, and sale of medical devices in Japan... more
Company facts
Reported company information and share structure.
Company
Share structure
| Market Cap | $5.66B | Exchange | JPX |
| Sector | Healthcare | Industry | Medical - Instruments & Supplies |
| Country | JP | CEO | Kenji Miyata |
| IPO Date | 2005-06-17 | CAGR | 14.89% |
| Employees | 10,177 | Website | www.asahi-intecc.co.jp |
| Div. Yield | 235.25% | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | 235.25% |
7747.T chart loading...
Key metrics
Reported fundamentals and market-derived technical indicators.
Fundamentals
Technicals
| EV | $4.80B | P/E | 27.97 | Forward P/E | — | PEG | 0.72 |
| P/S | 0.03 | P/B | 0.02 | P/CF | — | P/FCF | — |
| Sales | $912.83M | Sales 1Y | 21.16% | Sales 3Y | 61.4% | Sales 5Y | 136.43% |
| EPS | $0.76 | EPS 1Y | 157.01% | EPS 3Y | 149.88% | EPS 5Y | 217.09% |
| Sales QoQ | -0.13% | EPS QoQ | -42.54% | Sales QoQ Avg | 7.68% | EPS QoQ Avg | 24.41% |
| Gross Margin | 70.45% | Operating Margin | 30.96% | Profit Margin | 22.06% | ROCE | 24.18% |
| ROA | 15% | ROE | 20% | Altman Z Score | 16.59 | Piotroski Score | 7 |
| Current Ratio | 3.78 | Quick Ratio | 2.86 | Cash Ratio | 2 | Op. CF Ratio | — |
| Debt/Equity | 0.05 | Debt/Assets | 0.04 | Lt Debt/Equity | 0.04 | Lt Debt/Cap. | 0.02 |
| Intrst Cov. | 338.5 | Inventory Turnover | 1.44 | Asset Turnover | 0.67 | Receivables Turnover | 7.03 |
| Enterprise Value | $4.80B | P/E Ratio | 27.97 |
| Forward P/E | — | PEG Ratio | 0.72 |
| P/S Ratio | 0.03 | P/B Ratio | 0.02 |
| P/CF Ratio | — | P/FCF Ratio | — |
| EPS | $0.76 | EPS Growth 1Y | 157.01% |
| EPS Growth 3Y | 149.88% | EPS Growth 5Y | 217.09% |
| Revenue Growth 1Y | 21.16% | Gross Margin | 70.45% |
| Operating Margin | 30.96% | Profit Margin | 22.06% |
| ROE | 20% | ROA | 15% |
| ROCE | 24.18% | Current Ratio | 3.78 |
| Quick Ratio | 2.86 | Cash Ratio | 2 |
| Debt/Equity | 0.05 | Interest Coverage | 338.5 |
| Altman Z Score | 16.59 | Piotroski Score | 7 |
Asahi Intecc (7747.T) valuation & financials
Asahi Intecc (7747.T) has a market capitalization of $5.66B and trades at a price-to-earnings ratio of 28.0. It operates in the Healthcare sector (Medical - Instruments & Supplies).
Asahi Intecc's revenue grew +21.2% over the last year.
Asahi Intecc's next earnings report is scheduled for November 13, 2026 (provider scheduled date); analysts estimate EPS of $0.26. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)